Skip to main content
Clinical Trials/NCT03926312
NCT03926312
Completed
Not Applicable

Smart Device-based Cardiac Rehabilitation After Myocardial Intervention

Charles University, Czech Republic1 site in 1 country64 target enrollmentJune 19, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Charles University, Czech Republic
Enrollment
64
Locations
1
Primary Endpoint
Functional capacity change
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to evaluate the influence of cardiac rehabilitation based on smart band use and telemonitoring on functional capacity change and risk factors control among patients hospitalized for acute myocardial infarction.

Registry
clinicaltrials.gov
Start Date
June 19, 2019
End Date
October 5, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Charles University, Czech Republic
Responsible Party
Principal Investigator
Principal Investigator

Peter Wohlfahrt

Principal Investigator

Institute for Clinical and Experimental Medicine

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent with the study
  • Men and women \>18 years of age
  • Patients ≥1 and ≤6 months after type I myocardial infarction
  • Physical inactivity before MI defined as the absence of moderate to vigorous exercise for at least 30 minutes 5 or more days a week

Exclusion Criteria

  • Heart failure NYHA IIIB-IV
  • Planned coronary revascularization
  • Planned major surgery within the next 12 months
  • Inability to walk for any reason
  • Comorbidities that would preclude adherence to the rehabilitation program (e.g. arthrosis, active malignancy, major depression or other significant psychiatric disorder, cognitive impairment) - at the discretion of the physician
  • Life expectancy less than 12 months
  • Inability to operate the smart-watch

Outcomes

Primary Outcomes

Functional capacity change

Time Frame: 3 months

6-minute walk test distance and maximal oxygen consumption (VO2 max) change after 3 months of the intervention

Secondary Outcomes

  • Body fat percentage(3 months)
  • Waist circumference(3 months)
  • Blood pressure(3 months)
  • Smoking cessation(3 months)
  • Lipid levels(3 months)
  • Glycated hemoglobin(3 months)

Study Sites (1)

Loading locations...

Similar Trials